Tuberous sclerosis: genes and variants
Explore variant evidence for Tuberous sclerosis across 3 analyzed proteins (TSC2, TSC1, SERPINC1). Linked ClinVar records include 77 pathogenic or likely pathogenic variants, 3,319 variants of uncertain significance and 674 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Tuberous sclerosis
TSC2: Tuberin
Together with TSC1, it inactivates RHEB and restrains mTORC1 when growth conditions are unfavorable. Loss-of-function variants cause tuberous sclerosis complex with hamartomas and tumors affecting the brain, kidneys, skin, heart, lungs, and other organs.
59 ClinVar pathogenic / likely pathogenic and 2,081 uncertain variants in TSC2 have source records linked to Tuberous sclerosis. Association strength is not clinical gene validity.
TSC1: Hamartin
Together with TSC2, it restrains RHEB and mTORC1 signaling, preventing inappropriate cell growth when nutrients or growth signals are limited. Loss-of-function variants cause tuberous sclerosis complex with hamartomas and tumors in the brain, kidney, skin, heart, lungs, and other organs.
18 ClinVar pathogenic / likely pathogenic and 1,911 uncertain variants in TSC1 have source records linked to Tuberous sclerosis. Association strength is not clinical gene validity.
SERPINC1: Antithrombin-III
It neutralizes thrombin and several activated coagulation proteases and is greatly accelerated by heparin-like molecules. Heterozygous deficiency causes a strong inherited predisposition to venous thrombosis and can reduce responsiveness to heparin.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SERPINC1 have source records linked to Tuberous sclerosis. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): NTHL1.
Where Tuberous sclerosis variants cluster
- TSC2 Rap-GAP (positions 1531–1758): 15 of 37 ClinVar pathogenic / likely pathogenic variants, 3.2× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Tuberous sclerosis
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| TSC2 G1551E | 1551 | Rap-GAP | Pathogenic / likely pathogenic (★★) |
| TSC1 L191H | 191 | Pathogenic / likely pathogenic (★★) | |
| TSC2 V709D | 709 | Pathogenic / likely pathogenic (★★) | |
| TSC2 G1595E | 1595 | Rap-GAP | Pathogenic / likely pathogenic (★★) |
| TSC2 P1675R | 1675 | Rap-GAP | Pathogenic / likely pathogenic (★★) |
| TSC1 L61P | 61 | Pathogenic / likely pathogenic (★★) | |
| TSC1 K121N | 121 | Pathogenic / likely pathogenic (★★) | |
| TSC1 K121M | 121 | Pathogenic / likely pathogenic (★★) | |
| TSC2 V909D | 909 | Pathogenic / likely pathogenic (★★) | |
| TSC2 T913P | 913 | Pathogenic / likely pathogenic (★★) | |
| TSC2 P1497L | 1497 | Pathogenic / likely pathogenic (★★) | |
| TSC2 I1747N | 1747 | Rap-GAP | Pathogenic / likely pathogenic (★★) |
| TSC1 G132D | 132 | Pathogenic / likely pathogenic (★★) | |
| TSC1 F216S | 216 | Pathogenic / likely pathogenic (★★) | |
| TSC1 M224R | 224 | Pathogenic / likely pathogenic (★★) | |
| TSC2 P1453L | 1453 | Pathogenic / likely pathogenic (★★) | |
| TSC1 G81D | 81 | Pathogenic / likely pathogenic (★★) | |
| TSC2 P1441L | 1441 | Pathogenic / likely pathogenic (★★) | |
| TSC2 G1551R | 1551 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC1 L191R | 191 | Pathogenic / likely pathogenic (★) | |
| TSC2 R622G | 622 | Pathogenic / likely pathogenic (★) | |
| TSC2 I893T | 893 | Pathogenic / likely pathogenic (★) | |
| TSC2 R622P | 622 | Pathogenic / likely pathogenic (★) | |
| TSC2 V709G | 709 | Pathogenic / likely pathogenic (★) | |
| TSC2 C900Y | 900 | Pathogenic / likely pathogenic (★) | |
| TSC2 C900G | 900 | Pathogenic / likely pathogenic (★) | |
| TSC2 I912T | 912 | Pathogenic / likely pathogenic (★) | |
| TSC2 Y1549H | 1549 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 G1595R | 1595 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 P1675S | 1675 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC1 L61R | 61 | Pathogenic / likely pathogenic (★) | |
| TSC1 L93Q | 93 | Pathogenic / likely pathogenic (★) | |
| TSC1 F188V | 188 | Pathogenic / likely pathogenic (★) | |
| TSC1 R190P | 190 | Pathogenic / likely pathogenic (★) | |
| TSC2 D1590Y | 1590 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 L243P | 243 | Required for interaction with TSC1 | Pathogenic / likely pathogenic (★) |
| TSC2 E281D | 281 | Required for interaction with TSC1 | Pathogenic / likely pathogenic (★) |
| TSC2 G300V | 300 | Required for interaction with TSC1 | Pathogenic / likely pathogenic (★) |
| TSC2 I342N | 342 | Required for interaction with TSC1 | Pathogenic / likely pathogenic (★) |
| TSC2 I346N | 346 | Required for interaction with TSC1 | Pathogenic / likely pathogenic (★) |
| TSC2 A508D | 508 | Pathogenic / likely pathogenic (★) | |
| TSC2 Y598N | 598 | Pathogenic / likely pathogenic (★) | |
| TSC2 V705G | 705 | Pathogenic / likely pathogenic (★) | |
| TSC2 T849P | 849 | Pathogenic / likely pathogenic (★) | |
| TSC2 H1019P | 1019 | Pathogenic / likely pathogenic (★) | |
| TSC2 D1028V | 1028 | Pathogenic / likely pathogenic (★) | |
| TSC2 M1029R | 1029 | Pathogenic / likely pathogenic (★) | |
| TSC2 R1044T | 1044 | Pathogenic / likely pathogenic (★) | |
| TSC2 R1056S | 1056 | Pathogenic / likely pathogenic (★) | |
| TSC2 R1200G | 1200 | Pathogenic / likely pathogenic (★) | |
| TSC2 T1206P | 1206 | Pathogenic / likely pathogenic (★) | |
| TSC2 Y1505H | 1505 | Pathogenic / likely pathogenic (★) | |
| TSC2 V1531L | 1531 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 D1541Y | 1541 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 N1564K | 1564 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 R1570S | 1570 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 D1612Y | 1612 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 H1620P | 1620 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 M1625K | 1625 | Rap-GAP | Pathogenic / likely pathogenic (★) |
| TSC2 V1646L | 1646 | Rap-GAP | Pathogenic / likely pathogenic (★) |
Showing 60 of 77.
Uncertain variants prioritized for review in Tuberous sclerosis
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| TSC1 R190H | 190 | Conflicting reports (★) | +7: 4 other pathogenic changes within 3 positions; R190P at the same position is pathogenic; seen in 4.1e-06 of gnomAD DNA copies; REVEL 0.811 | |
| TSC2 V709A | 709 | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; V709D at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.866 | |
| TSC2 M1029V | 1029 | Uncertain (★★) | +7: 2 other pathogenic changes within 3 positions; M1029R at the same position is pathogenic; seen in 2e-06 of gnomAD DNA copies; REVEL 0.793 | |
| TSC1 R190C | 190 | Conflicting reports (★) | +6: 4 other pathogenic changes within 3 positions; R190P at the same position is pathogenic; REVEL 0.779 | |
| TSC2 M1029L | 1029 | Conflicting reports (★) | +6: 2 other pathogenic changes within 3 positions; M1029R at the same position is pathogenic; seen in 6.9e-07 of gnomAD DNA copies; REVEL 0.719 | |
| TSC2 Y598S | 598 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; Y598N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.92 | |
| TSC2 C900R | 900 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; C900Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 | |
| TSC2 I912L | 912 | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; I912T at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.70 | |
| TSC2 D1590V | 1590 | Rap-GAP | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; D1590Y at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.65 |
| TSC2 T913I | 913 | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; T913P at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.72 | |
| TSC2 P1589L | 1589 | Rap-GAP | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; P1589S at the same position is pathogenic; seen in 6.6e-06 of gnomAD DNA copies; REVEL 0.753 |
| TSC2 I912V | 912 | Uncertain (★★) | +6: 3 other pathogenic changes within 3 positions; I912T at the same position is pathogenic; seen in 1.4e-06 of gnomAD DNA copies; REVEL 0.686 | |
| TSC2 Y598H | 598 | Uncertain (★★) | +6: 2 other pathogenic changes within 3 positions; Y598N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.90 |
Which prediction tools work for Tuberous sclerosis
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- ESM1b (LLR): 91 out of 100
- CATVariant: 91 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- EVE: 89 out of 100
- AlphaMissense: 89 out of 100
- MetaSVM: 79 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaLR: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 78 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MutPred: 77 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 77 out of 100
- REVEL: 74 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CADD: 71 out of 100
- phyloP: 68 out of 100
- SpliceAI: 57 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 54 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Ovarian cancer also has ClinVar records linked to TSC2 variants; they fall mostly in different places as the Tuberous sclerosis variants (4 pathogenic / likely pathogenic).
Diseases related to Tuberous sclerosis
- Ovarian cancer, also linked to TSC1 and TSC2
- Isolated focal cortical dysplasia, also linked to TSC1 and TSC2
- Lymphangiomyomatosis, also linked to TSC1 and TSC2
- Hereditary antithrombin deficiency, also linked to SERPINC1
- Familial adenomatous polyposis, also linked to TSC2
- Urinary bladder cancer, also linked to TSC1
- Hepatocellular carcinoma, also linked to TSC2
- Myocardial infarction, also linked to SERPINC1
Frequently asked questions
Which genes have records linked to Tuberous sclerosis?
This view contains 3 analyzed proteins: TSC2, TSC1, SERPINC1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 77 pathogenic or likely pathogenic variants, 3,319 variants of uncertain significance and 674 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 13 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 4,357 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center